Literature DB >> 15482755

Oocyte quality in patients with severe ovarian hyperstimulation syndrome: a self-controlled clinical study.

Francisco Fábregues1, Joana Peñarrubia, Ester Vidal, Gemma Casals, Juan A Vanrell, Juan Balasch.   

Abstract

OBJECTIVE: To investigate the oocyte quality in patients with severe ovarian hyperstimulation syndrome (OHSS).
DESIGN: Self-controlled clinical study.
SETTING: University teaching hospital. PATIENT(S): Twenty-two patients from our assisted reproductive technology (ART) program who developed severe OHSS during their first controlled ovarian hyperstimulation for IVF or intracytoplasmic sperm injection (ICSI) (OHSS cycles) during a period of 10 years and had a second ART attempt performed in our center in which OHSS did not develop (control cycles). INTERVENTION(S): IVF and ICSI. MAIN OUTCOME MEASURE(S): Oocyte yield and quality, fertilization rate, embryo yield and quality, implantation rate, and pregnancy rate. RESULT(S): The total number of oocytes retrieved and the mean number of metaphase II oocytes were significantly higher in patients with OHSS than in control cycles. Fertilization rates were similar in both groups of ART cycles, and thus the number of viable embryos were significantly higher in OHSS cycles. Implantation and pregnancy rates were similar in OHSS and control cycles. Oocyte and embryo yield and quality were similar in early and late OHSS. Oocyte yield and quality, embryological outcome, and implantation and pregnancy rates were similar in patients with and without polycystic ovarian syndrome (PCOS) both in cycles developing OHSS and control cycles. CONCLUSION(S): Oocyte quality is not compromised in severe OHSS cycles irrespective of whether patients had or did not have PCOS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15482755     DOI: 10.1016/j.fertnstert.2004.02.131

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  4 in total

Review 1.  Novel Concepts for Inducing Final Oocyte Maturation in In Vitro Fertilization Treatment.

Authors:  Ali Abbara; Sophie A Clarke; Waljit S Dhillo
Journal:  Endocr Rev       Date:  2018-10-01       Impact factor: 19.871

2.  A unique human chorionic gonadotropin antagonist suppresses ovarian hyperstimulation syndrome in rats.

Authors:  Pratibhasri A Vardhana; Martin A Julius; Susan V Pollak; Evan G Lustbader; Rhonda K Trousdale; Joyce W Lustbader
Journal:  Endocrinology       Date:  2009-05-14       Impact factor: 4.736

3.  Factors Associated with Ovarian Hyperstimulation Syndrome (OHSS) Severity in Women With Polycystic Ovary Syndrome Undergoing IVF/ICSI.

Authors:  Bo Sun; Yujia Ma; Lu Li; Linli Hu; Fang Wang; Yile Zhang; Shanjun Dai; Yingpu Sun
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-19       Impact factor: 5.555

4.  Use of Follicular Output Rate to Predict Intracytoplasmic Sperm Injection Outcome.

Authors:  Rehana Rehman; Rozina Mustafa; Mukhtiar Baig; Sara Arif; Muhammad Faisal Hashmi
Journal:  Int J Fertil Steril       Date:  2016-06-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.